Hanall Biopharma
KOSPI · Healthcare · ₩2T
₩38,600+0.13%
Price
49,650원
38,600원
Jul 23, 26Oct 27, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue₩44.8B+1.2%
Operating Income₩1.6B-71.4%
Net Income-₩300M+98.4%
6/'26 vs prev quarter
Company Health
Market Cap₩2T
Operating Margin+2.9%
Cash on Hand302억원1.4% of market cap
Free Cash Flow-54억원-0.3% of market cap
Short Volume 9.1% · as of 26.10.26
Among 97 제약 peers
LowMedianHigh
PSR12.9xmedian 0.7xPBR13.0xmedian 0.8xROE-15.4%median +5.2%
